Skip to main content
. 2022 Nov 11;48(4):439–459. doi: 10.1007/s10867-022-09618-8

Table 1.

Description and values of the estimated parameters of Eqs. (1)–(4) from the literature [5] and [6]

Parameter Description Value [5, 6]
αT Glioma growth rate 1.575 (ml2 g−1 day−1)
KT Glioma carrying capacity 2 (g/ml)
dTI Decreased rate of glioma due to immune response 0.072 (day−1)
αTI The recruitment rate of immune systems cells due to glioma 0.0003 (day−1)
dT Glioma natural decay rate 0.0001 (day−1)
dI The natural decay rate of immune system cells 0.01 (day−1)
αs Immune system cell recruitment rate 0.7 (day−1)
ν Baseline immune system cell production rate 0.7 (day−1)
dTσ Glucose consumption rate by glioma 1 (day−1)
ασ Transfer rate of glucose from serum to brain 20 (day−1)
σmin Minimum glucose intake rate to serum 0.0008 (g/ml)
σ0 Maximum variation in the rate of glucose intake 0.0016 (g/ml)
1 Consumption of glucose in the brain by healthy cells 0.01 (day−1)
2 Consumption of metabolic glucose in serum 0.00625 (day−1)
dTT The rate of glioma cells killing immune cells 0.072 (day−1)